Sreeja Sreekumar

627 total citations
29 papers, 477 citations indexed

About

Sreeja Sreekumar is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sreeja Sreekumar has authored 29 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sreeja Sreekumar's work include HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Estrogen and related hormone effects (4 papers). Sreeja Sreekumar is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Estrogen and related hormone effects (4 papers). Sreeja Sreekumar collaborates with scholars based in United States, India and France. Sreeja Sreekumar's co-authors include Sreeharshan Sreeja, Juberiya M. Azeez, Deborah Heyl, Ayyalusamy Ramamoorthy, Florence Y. An, Sathiah Thennarasu, Charles E. Shelburne, Anmin Tan, Cedric Mpoy and Buck E. Rogers and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemistry and Cancer Research.

In The Last Decade

Sreeja Sreekumar

25 papers receiving 469 citations

Peers

Sreeja Sreekumar

MICRO

ONCOL

Julio R. Fernández Cuba

Gabriela M. Montero-Morán Mexico

Alyaa Dawoud Egypt

Huma Khan India

Mengxue Dong China

Zahid Rasul Niazi Pakistan

Tong Jin China

Chooi Ling Lim Malaysia

Makoto Tsuboi Japan

Felipe V. Pereira Brazil

Julio R. Fernández Cuba

Sreeja Sreekumar

251 ×1.6

78 ×0.5

42 ×0.4

45 ×0.5

MICRO

36 ×0.5

ONCOL

Citations per year, relative to Sreeja Sreekumar Sreeja Sreekumar (= 1×) peers Julio R. Fernández

Countries citing papers authored by Sreeja Sreekumar

Since Specialization

Citations

This map shows the geographic impact of Sreeja Sreekumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sreeja Sreekumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sreeja Sreekumar more than expected).

Fields of papers citing papers by Sreeja Sreekumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sreeja Sreekumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sreeja Sreekumar. The network helps show where Sreeja Sreekumar may publish in the future.

Co-authorship network of co-authors of Sreeja Sreekumar

This figure shows the co-authorship network connecting the top 25 collaborators of Sreeja Sreekumar. A scholar is included among the top collaborators of Sreeja Sreekumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sreeja Sreekumar. Sreeja Sreekumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sreekumar, Sreeja, et al.. (2025). Adjuvant Systemic Immunotherapies for Resected Stage III Melanoma: A Single-Centre Retrospective Clinical Practice Review. International Journal of Molecular Sciences. 26(2). 750–750.

Sreekumar, Sreeja, Élodie Montaudon, Ahmed Dahmani, et al.. (2025). Abstract P4-08-06: Onvansertib enhances the anti-tumor efficacy of trastuzumab deruxtecan in CDK4/6 inhibitor-resistant HR+/HER2- breast cancer patient-derived xenograft models. Clinical Cancer Research. 31(12_Supplement). P4–8. 1 indexed citations

Sreekumar, Sreeja, Pierre Painsec, Laura Sourd, et al.. (2024). Abstract PO2-04-09: Combination of the PLK1 Inhibitor Onvansertib and the PI3Kα Inhibitor Alpelisib Overcomes Palbociclib Resistance in PIK3CA-mutated HR+ Breast Cancer. Cancer Research. 84(9_Supplement). PO2–4. 1 indexed citations

Sreekumar, Sreeja, Élodie Montaudon, Pierre Painsec, et al.. (2024). PLK1 Inhibitor Onvansertib Enhances the Efficacy of Alpelisib in PIK3CA-Mutated HR-Positive Breast Cancer Resistant to Palbociclib and Endocrine Therapy: Preclinical Insights. Cancers. 16(19). 3259–3259. 1 indexed citations

Kar, Sujita Kumar, et al.. (2024). Media reporting of suicide notes from two Indian States: A content analysis. 0(0). 0–0.

Sreekumar, Sreeja & Robert J. Rubin. (2024). A Case of Pulmonary Mucormycosis Leading to Non-hepatic Hyperammonemia. A3563–A3563.

Sreekumar, Sreeja, et al.. (2023). Attitude towards mental illness among doctors working in a tertiary care centre: a cross-sectional study. SHILAP Revista de lepidopterología. 36(1). 363–363. 2 indexed citations

Sreekumar, Sreeja, Dong Zhou, Cedric Mpoy, et al.. (2023). Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer. International Journal of Molecular Sciences. 24(4). 3083–3083. 15 indexed citations

Lofgren, Kristopher A., et al.. (2022). Pan-cancer distribution of cleaved cell-surface amphiregulin, the target of the GMF-1A3 antibody drug conjugate. PubMed. 5(3). 226–231. 3 indexed citations

10.

Dehdashti, Farrokh, Melissa A. Reimers, Kooresh I. Shoghi, et al.. (2022). Pilot Study: PARP1 Imaging in Advanced Prostate Cancer. Molecular Imaging and Biology. 24(6). 853–861. 5 indexed citations

11.

Huynh, Truc T., Ellen M. van Dam, Sreeja Sreekumar, et al.. (2022). Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer. Pharmaceuticals. 15(6). 728–728. 24 indexed citations

12.

Lofgren, Kristopher A., et al.. (2021). Anti-tumor efficacy of an MMAE-conjugated antibody targeting cell surface TACE/ADAM17-cleaved Amphiregulin in breast cancer. PubMed. 4(4). 252–261. 9 indexed citations

13.

Menon, Vikas, et al.. (2021). Newspaper reporting of suicide news in a high suicide burden state in India: Is it compliant with international reporting guidelines?. Asian Journal of Psychiatry. 60. 102647–102647. 11 indexed citations

14.

Sreekumar, Sreeja, et al.. (2021). Attitude towards drug adherence in inpatients with bipolar affective disorder: a cross-sectional study. SHILAP Revista de lepidopterología. 34(1). 1 indexed citations

15.

Sreekumar, Sreeja, Kevin M. Levine, Matthew J. Sikora, et al.. (2020). Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast Carcinoma. Endocrinology. 161(9). 12 indexed citations

16.

Parsons, Benjamin M., Sreeja Sreekumar, Craig S. Richmond, et al.. (2019). Abstract 1317: Exceptional responses to crizotinib in breast cancer patients with somatic MET and ROS1 alterations. Cancer Research. 79(13_Supplement). 1317–1317. 2 indexed citations

17.

Sreekumar, Sreeja, et al.. (2016). Factors associated with resilience in wives of individuals with alcohol dependence syndrome. Indian Journal of Psychiatry. 58(3). 307–307. 11 indexed citations

18.

Boisen, M.M., Courtney L. Andersen, Sreeja Sreekumar, Andrew M. Stern, & Steffi Oesterreich. (2015). Treating gynecologic malignancies with selective estrogen receptor downregulators (SERDs): promise and challenges. Molecular and Cellular Endocrinology. 418. 322–333. 8 indexed citations

19.

Casà, Angelo, Daniel Hochbaum, Sreeja Sreekumar, Steffi Oesterreich, & Adrian V. Lee. (2015). The estrogen receptor alpha nuclear localization sequence is critical for fulvestrant-induced degradation of the receptor. Molecular and Cellular Endocrinology. 415. 76–86. 18 indexed citations

20.

Sreeja, Sreeharshan, et al.. (2015). Progesterone regulates the proliferation of breast cancer cells – in vitro evidence. Drug Design Development and Therapy. 9. 5987–5987. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact